ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

June Panel Meeting Dropped

June 3, 1977

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

Academies Updates Guidelines on Stem Cell Research. NIH Begins New T-R01 Program.

September 19, 2008